Clinical Trial Update: Efficacy of Methyl Aminolevulinate + Daylight in Patients With Facial Photodamage [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the efficacy of methyl aminolevulinate with daylight photodynamic therapy for facial photodamage. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Facial Photodamage

Drugs mentioned

• Methyl aminolevulinate (methyl aminolevulinate)

Snippet

Sponsor: Fundación Dermabase | Conditions: Facial Photodamage | Phase 2 | Status: COMPLETED